Diethylpropion sustained-release tabs CIV

Select the drug indication to add to your list

Diethylpropion sustained-release tabs

Only 4 drugs may be compared at once

Generic Name and Formulations:

Diethylpropion HCl 75mg; sust rel tabs.

Select therapeutic use:

Indications for Diethylpropion sustained-release tabs:

Short-term adjunct in management of exogenous obesity.


25mg 3 times daily 1 hr before meals and in midevening for night hunger or one 75mg sustained-release tab daily in midmorning.


Not recommended.


Arteriosclerosis. Hypertension. Hyperthyroidism. Glaucoma. Agitation. Drug or alcohol abuse. During or within 14 days of MAOIs.


Discontinue after a few weeks as tolerance to anorectic effect occurs. Epilepsy. Cardiovascular disease. Arrhythmias. Diabetes. Prescribe limited supply to prevent overdose. Pregnancy (Cat.B). Nursing mothers.

See Also:


Pharmacological Class:



Hypertensive crisis with MAOIs. Blocks guanethidine. Adverse reaction with alcohol. Arrhythmias may occur with general anesthetics. Antagonized by phenothiazines.

Adverse Reactions:

Abuse potential, impairment in hazardous activities, arrhythmias, hypertension, CNS overstimulation, psychosis, dry mouth, GI disturbances, urticaria, impotence, seizures, blood dyscrasias, dyspnea, hair loss, dysuria.


Formerly known under the brand names Tenuate, Tepanil (tabs); Tenuate Dospan, Tepanil Ten-tab (SR tabs).

How Supplied:

Contact supplier.